Barclays Downgrades Renault as Cost Savings Challenges Grow 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
SK Hynix Shares Surge on Record $28.6 Billion Buyback 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Samsung Shares Rise on $72 Billion Shareholder Return Plan 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
Alibaba Shares Fall as AI Spending Hits Profit 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
 - EconoTimes)
Add as a preferred source on Google
Dublin, May 08, 2018 -- The "Stem Cells in Drug Discovery & Toxicity Screening 2018" conference has been added to ResearchAndMarkets.com's offering.
Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.
Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda:
- 3D-Cell Culture Based Models
- Technologies in 3D-Cell Culture
- iPSC-derived Cells for Toxicity Testing & Screening
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Development
- Use of Microfluidics Organs-on-Chips for Toxicity Screening
Keynote Speakers
Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University
Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Gary Gintant
Research Fellow, Abbvie
Confirmed Speakers to Date
Ulrich Broeckel
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai
Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi
Research Associate Professor, The University of Missouri
Kennedy Okeyo
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation
Daniele Zink
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
For more information about this conference visit https://www.researchandmarkets.com/research/ndptbs/stem_cells_in?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Drug Abuse Screening, Stem Cells
